In studies of GLP-1RA therapy in individuals with type 2 diabetes, the most frequently reported adverse events tend to involve the gastrointestinal system, with nausea, vomiting, and diarrhea occurring in up to 51%, 19%, and 20% of patients, respectively [44]
Considering an increased thromboembolic risk among patients with diabetes mellitus 153,154,155,156,157 , we propose that physicians should consider prescribing antiplatelet or anticoagulating agents more actively in patients with diabetes mellitus to prevent thromboembolic events and their complications during the COVID-19 pandemic
Millennium Physicians
Will my insurance cover hormone replacement therapy
All three hold active community pharmacy licenses, and the patients prescription routes to whichever pharmacy is best positioned to ship